Literature DB >> 11905727

Women and lung cancer: does oestrogen play a role?

J M Siegfried1.   

Abstract

Smoking-related disease remains a major public-health problem. Large numbers of women continue to smoke, and new smokers are almost as likely to be female as male. Lung cancer is still a largely incurable disease; annual lung-cancer mortality in women exceeds that of breast cancer, and lung cancer now accounts for 12% of all new female cancer cases. The results of several studies suggest that women are more susceptible than men to lung cancer and to conditions that predispose to this cancer, such as chronic obstructive pulmonary disease. There is still much controversy about whether there is an increased lung-cancer risk in women across all populations. Many epidemiological studies have been negative or equivocal when comparing male and female lung-cancer risk. This article is not intended to be a comprehensive review of all epidemiological studies, or of all possible lung-cancer risk factors. Lung-cancer incidence and risk in women are discussed, and evidence for possible mechanisms of increased female risk are presented, including the role of oestrogen in the development of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11905727     DOI: 10.1016/S1470-2045(01)00457-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  50 in total

1.  Soy intake is associated with lower lung cancer risk: results from a meta-analysis of epidemiologic studies.

Authors:  Wan-Shui Yang; Puthiery Va; Man-Yu Wong; Huan-Ling Zhang; Yong-Bing Xiang
Journal:  Am J Clin Nutr       Date:  2011-11-09       Impact factor: 7.045

2.  Effect of carcinogenic acrolein on DNA repair and mutagenic susceptibility.

Authors:  Hsiang-Tsui Wang; Yu Hu; Dan Tong; Jian Huang; Liya Gu; Xue-Ru Wu; Fung-Lung Chung; Guo-Min Li; Moon-shong Tang
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

Review 3.  Pathogenesis of lung cancer: 100 year report.

Authors:  York E Miller
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09       Impact factor: 6.914

Review 4.  Sex-specific aspects of tumor therapy.

Authors:  Kerstin Borgmann; Ekkehard Dikomey; Cordula Petersen; Petra Feyer; Ulrike Hoeller
Journal:  Radiat Environ Biophys       Date:  2009-02-26       Impact factor: 1.925

5.  Gender differences in pulmonary regenerative response to naphthalene-induced bronchiolar epithelial cell injury.

Authors:  J R Oliver; R Kushwah; J Wu; E Cutz; H Yeger; T K Waddell; J Hu
Journal:  Cell Prolif       Date:  2009-07-09       Impact factor: 6.831

6.  17β-Estradiol inhibits phosphorylation of stromal interaction molecule 1 (STIM1) protein: implication for store-operated calcium entry and chronic lung diseases.

Authors:  John T Sheridan; Rodney C Gilmore; Michael J Watson; Christopher B Archer; Robert Tarran
Journal:  J Biol Chem       Date:  2013-10-10       Impact factor: 5.157

7.  GSTP1 Ile105Val polymorphism is associated with lung cancer risk among Asian population and smokers: an updated meta-analysis.

Authors:  Chun-hua Xu; Qin Wang; Ping Zhan; Qian Qian; Li-Ke Yu
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

8.  Invited commentary: the etiology of lung cancer in men compared with women.

Authors:  Anthony J Alberg; Kristin Wallace; Gerard A Silvestri; Malcolm V Brock
Journal:  Am J Epidemiol       Date:  2013-02-20       Impact factor: 4.897

9.  Antiestrogen use and survival of women with non-small cell lung cancer in Manitoba, Canada.

Authors:  S A Lother; G A Harding; G Musto; S Navaratnam; M W Pitz
Journal:  Horm Cancer       Date:  2013-05-29       Impact factor: 3.869

10.  Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen.

Authors:  Li-Jie Wang; Jian Li; Fang-Ran Hao; Yin Yuan; Jing-Yun Li; Wei Lu; Tian-Yan Zhou
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.